BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12657581)

  • 1. Psychometric performance of the NEI VFQ-25 in visually normal Latinos: the Los Angeles Latino Eye Study.
    Globe D; Varma R; Azen SP; Paz S; Yu E; Preston-Martin S;
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1470-8. PubMed ID: 12657581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of visual impairment on self-reported visual functioning in Latinos: The Los Angeles Latino Eye Study.
    Globe DR; Wu J; Azen SP; Varma R;
    Ophthalmology; 2004 Jun; 111(6):1141-9. PubMed ID: 15177964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric performance of the National Eye Institute visual function questionnaire in Latinos and non-Latinos.
    Baker RS; Bazargan M; Calderón JL; Hays RD
    Ophthalmology; 2006 Aug; 113(8):1363-71. PubMed ID: 16877075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER.
    Broman AT; Munoz B; West SK; Rodriguez J; Sanchez R; Snyder R; Klein R
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):606-13. PubMed ID: 11222517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-Related Macular Degeneration and Quality of Life in Latinos: The Los Angeles Latino Eye Study.
    Choudhury F; Varma R; Klein R; Gauderman WJ; Azen SP; McKean-Cowdin R;
    JAMA Ophthalmol; 2016 Jun; 134(6):683-90. PubMed ID: 27124819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study.
    McKean-Cowdin R; Wang Y; Wu J; Azen SP; Varma R;
    Ophthalmology; 2008 Jun; 115(6):941-948.e1. PubMed ID: 17997485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of severity and bilaterality of visual impairment on health-related quality of life.
    Varma R; Wu J; Chong K; Azen SP; Hays RD;
    Ophthalmology; 2006 Oct; 113(10):1846-53. PubMed ID: 16889831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the 25-item National Eye Institute Visual Function Questionnaire.
    Mangione CM; Lee PP; Gutierrez PR; Spritzer K; Berry S; Hays RD;
    Arch Ophthalmol; 2001 Jul; 119(7):1050-8. PubMed ID: 11448327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between self-reported depression and self-reported visual function in Latinos.
    Paz SH; Globe DR; Wu J; Azen SP; Varma R;
    Arch Ophthalmol; 2003 Jul; 121(7):1021-7. PubMed ID: 12860807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported comorbidities and visual function in a population-based study: the Los Angeles Latino Eye Study.
    Globe DR; Varma R; Torres M; Wu J; Klein R; Azen SP;
    Arch Ophthalmol; 2005 Jun; 123(6):815-21. PubMed ID: 15955983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal changes in visual acuity and health-related quality of life: the Los Angeles Latino Eye study.
    McKean-Cowdin R; Varma R; Hays RD; Wu J; Choudhury F; Azen SP;
    Ophthalmology; 2010 Oct; 117(10):1900-7, 1907.e1. PubMed ID: 20570364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators.
    Mangione CM; Lee PP; Pitts J; Gutierrez P; Berry S; Hays RD
    Arch Ophthalmol; 1998 Nov; 116(11):1496-504. PubMed ID: 9823352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration.
    Revicki DA; Rentz AM; Harnam N; Thomas VS; Lanzetta P
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):712-7. PubMed ID: 19797233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-cultural validation of the National Eye Institute Visual Function Questionnaire.
    Mollazadegan K; Huang J; Khadka J; Wang Q; Yang F; Gao R; Pesudovs K
    J Cataract Refract Surg; 2014 May; 40(5):774-84. PubMed ID: 24767911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and cross-cultural adaptation of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) in Serbian patients.
    Kovac B; Vukosavljevic M; Djokic Kovac J; Resan M; Trajkovic G; Jankovic J; Smiljanic M; Grgurevic A
    Health Qual Life Outcomes; 2015 Sep; 13():142. PubMed ID: 26370558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of visual field loss and health-related quality of life.
    McKean-Cowdin R; Varma R; Wu J; Hays RD; Azen SP;
    Am J Ophthalmol; 2007 Jun; 143(6):1013-23. PubMed ID: 17399676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric Validation of the National Eye Institute Visual Function Questionnaire - 25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma.
    Nordmann JP; Viala M; Sullivan K; Arnould B; Berdeaux G
    Pharmacoeconomics; 2004; 22(3):197-206. PubMed ID: 14871166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a new Rasch-based scoring algorithm for the National Eye Institute Visual Functioning Questionnaire to improve its interpretability.
    Petrillo J; Bressler NM; Lamoureux E; Ferreira A; Cano S
    Health Qual Life Outcomes; 2017 Aug; 15(1):157. PubMed ID: 28807029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remediating serious flaws in the National Eye Institute Visual Function Questionnaire.
    Pesudovs K; Gothwal VK; Wright T; Lamoureux EL
    J Cataract Refract Surg; 2010 May; 36(5):718-32. PubMed ID: 20457362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The psychometric validity of the NEI VFQ-25 for use in a low-vision population.
    Marella M; Pesudovs K; Keeffe JE; O'Connor PM; Rees G; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2878-84. PubMed ID: 20089878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.